1966
DOI: 10.1139/o66-025
|View full text |Cite
|
Sign up to set email alerts
|

The in Vivo Antitumor Activity of Certain Short Chain Fatty Acids

Abstract: Antitumor activity has been demonstrated against Ehrlich, L.1210 leukemia, and to a less extent against TA3 mammary carcinoma ascites cells by a group of short chain fatty acids. Activity is confined to the finely suspended ester forms of the acids and seems to be associated with the carboxyl end of the molecule. The compounds appear to have no effect upon the production of normal white blood cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1976
1976
2006
2006

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…The inhibition of glycolysis in tumours would result in an energy loss which might be reflected in a reduced growth rate. It is of interest, therefore, that antitumor activity has been observ ed with fatty acids [15][16][17][18], This action was observed to be influenced by the degree of saturation of the fatty acids and may be affected by the extent to which different fatty acids and related compounds are subject to (3-oxidation [18]. The inhibition of glycolytic enzymes by fatty acids suggests a possible mechanism for their action on tumors.…”
Section: Discussionmentioning
confidence: 99%
“…The inhibition of glycolysis in tumours would result in an energy loss which might be reflected in a reduced growth rate. It is of interest, therefore, that antitumor activity has been observ ed with fatty acids [15][16][17][18], This action was observed to be influenced by the degree of saturation of the fatty acids and may be affected by the extent to which different fatty acids and related compounds are subject to (3-oxidation [18]. The inhibition of glycolytic enzymes by fatty acids suggests a possible mechanism for their action on tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Ethyl pivalate (275) has demonstrated antitumor activity against Ehrlich L-1210 leukemia (284). Compound pivaloylphenothiazine, 276, showed 24.3% inhibition of Ehrlichtype tumors in male mice (285).…”
Section: Biological Activities Of Neo Acids and Derivativesmentioning
confidence: 99%